Workflow
安图生物(603658) - 2020 Q1 - 季度财报
AutobioAutobio(SH:603658)2020-04-28 16:00

Financial Performance - Net profit attributable to shareholders decreased by 23.08% to CNY 93,119,745.83 year-on-year[4] - Operating income for the quarter was CNY 550,376,711.12, a slight increase of 0.44% compared to the same period last year[4] - Basic and diluted earnings per share decreased by 24.14% to CNY 0.22[4] - Net profit for Q1 2020 was CNY 91,544,717.74, down from CNY 122,433,008.91 in Q1 2019, reflecting a decrease of approximately 25.2%[25] - Earnings per share for Q1 2020 was CNY 0.22, compared to CNY 0.29 in Q1 2019, showing a decline of about 24.1%[25] - Total operating revenue for Q1 2020 was CNY 550,376,711.12, a slight increase from CNY 547,965,150.55 in Q1 2019, representing a growth of approximately 0.25%[24] - Total operating costs for Q1 2020 were CNY 456,469,094.87, up from CNY 411,192,285.17 in Q1 2019, indicating an increase of about 11.0%[24] - The company reported a significant increase in investment income, which rose to CNY 10,704,064.51 from CNY 3,310,690.69 in the previous year, marking an increase of about 223.5%[24] Cash Flow - Net cash flow from operating activities decreased by 42.07% to CNY 63,382,159.77 compared to the previous year[4] - The net cash flow from operating activities increased to ¥280,285,342.49 in Q1 2020, up from ¥151,866,394.32 in Q1 2019, representing an increase of 84.6%[31] - Cash flow from operating activities generated ¥63.38 million, a decline of 42.1% compared to ¥109.40 million in Q1 2019[29] - The company reported a significant increase in investment cash inflow to approximately ¥1.17 billion, compared to ¥629.83 million in Q1 2019[29] - The net cash flow from financing activities was ¥140,805,218.23 in Q1 2020, up from ¥71,278,830.07 in Q1 2019, reflecting a growth of 97.5%[32] Assets and Liabilities - Total assets increased by 11.08% to CNY 4,728,469,351.04 compared to the end of the previous year[4] - The company’s total liabilities increased by 195.89% to RMB 1,015,258,801.08, mainly due to increased borrowings from the controlling shareholder[12] - The company’s total assets at the end of the reporting period were RMB 1,217,907,210.70, reflecting a 127.16% increase in capital reserves[13] - Current assets totaled ¥2,394,149,394.94, up from ¥2,017,285,663.73, indicating an increase of about 18.63% year-over-year[19] - Total liabilities decreased to ¥1,494,751,768.13 from ¥1,622,295,404.57, a reduction of about 7.86%[20] - The company’s total equity increased to ¥3,233,717,582.91 from ¥2,634,574,247.66, representing a growth of approximately 22.73%[20] Shareholder Information - The total number of shareholders at the end of the reporting period was 8,413[7] - The largest shareholder, Zhengzhou Antu Industrial Group Co., Ltd., held 58.38% of the shares[7] Government Support - The company received government subsidies amounting to CNY 10,728,900.00 during the quarter[5] - Other income rose significantly by 1,072.32% to RMB 10,728,900.00, primarily from increased government subsidies received[14] Research and Development - Research and development expenses for Q1 2020 amounted to CNY 70,318,579.77, an increase from CNY 64,206,464.16 in Q1 2019, representing a growth of approximately 9.8%[24] - Research and development expenses increased to ¥32.77 million, up 10.3% from ¥29.50 million in Q1 2019[26] Financial Position - The total liabilities to equity ratio improved, indicating a stronger financial position compared to the previous year[20] - The company has implemented new revenue and leasing standards starting from 2020, which may impact future financial reporting and performance metrics[32]